[1]
A. Pal, B. Panja, T. Dutta, B. Subhrojyoti, S. Nath, and S. Bhattacharjee, “Ponatinib: a miracle or a disaster in chronic myeloid leukemia”, Int J Basic Clin Pharmacol, vol. 3, no. 6, pp. 933–936, Jan. 2017.